Synelvia has the expertise to perform in-house analytical services (biomarkers and drugs analysis)
Synelvia set up innovative models provide a reliable tool to evaluate drug & product activity/efficacy in early phase development
Synelvia proposes innovating imaging techniques for the exploration and quantification of biomarkers
Synelvia proposes a scientific support including statistical and biochemical interpretations to help decision making.
Integrated solutions to evaluate drug & product efficacy
Early studies (bioanalysis/biochemistry) to identify leads
Independent Contract Research organization
specialized in the evaluation
of drug & molecules effects
using innovative technologies
within a regulatory framework.
© 2021 SYNELVIA. SAS Legal mentions